Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
6.77
+0.02 (0.30%)
Dec 4, 2025, 2:26 PM EST - Market open
Evolus Market Cap
Evolus has a market cap or net worth of $438.83 million as of December 4, 2025. Its market cap has decreased by -42.77% in one year.
Market Cap
438.83M
Enterprise Value
550.20M
1-Year Change
-42.77%
Ranking
Category
Stock Price
$6.77
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.32M to $438.83M, an increase of 61.74%. That is a compound annual growth rate of 6.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 437.53M | -37.41% |
| Dec 31, 2024 | 699.07M | 14.94% |
| Dec 29, 2023 | 608.22M | 43.99% |
| Dec 30, 2022 | 422.41M | 16.75% |
| Dec 31, 2021 | 361.81M | 219.06% |
| Dec 31, 2020 | 113.40M | -72.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |